Bridging the Gap: Why Reproductive and Maternal Health Needs a New Financial Paradigm

The United States is currently navigating a profound reproductive and maternal health crisis, characterized by alarming mortality rates, systemic racial disparities, and a volatile policy landscape that threatens access to essential care. For practitioners on the ground, this is not a theoretical debate—it is a daily reality of navigating resource scarcity and mounting patient need.

As the CEO of Rhia Ventures, I witness firsthand how the very organizations tasked with protecting women’s health are being squeezed by a traditional financial system that is ill-equipped to value their outcomes. While impact investors have signaled an increasing eagerness to support reproductive and maternal health, many remain at a loss regarding how to deploy capital effectively. To move beyond the status quo, we must reconcile the divide between conventional investment metrics and the urgent, ground-level requirements of health equity.

The Landscape: A Crisis of Capital and Care

The current maternal health crisis in the U.S. is not merely a clinical failure; it is a structural one. Despite the U.S. spending more on healthcare than any other high-income nation, Black birthing people remain three times more likely to die from pregnancy-related causes than their white counterparts, a disparity that persists regardless of education or income levels.

This crisis is compounded by a funding environment that remains fundamentally misaligned with the needs of the population. Although 2024 was a record year for women’s health investment, a mere 2% of venture capital (VC) healthcare funding is directed toward women’s health. Furthermore, research indicates that the closer a founder is to the health issue they are solving, the more skepticism they face from traditional investors. This creates a perverse incentive structure: the people best positioned to solve these crises are systematically starved of the resources necessary to scale their solutions.

Chronology of the Shift: From Philanthropy to Impact Investment

The movement to secure reproductive and maternal health through sustainable financial models has evolved significantly over the past two decades.

• Early 2000s: The field relied almost exclusively on philanthropic grants. While vital, these grants often lacked the long-term sustainability required to build robust infrastructure.
• The Mid-2010s: Organizations like the Tara Health Foundation began experimenting with mission-driven investment, recognizing that grants alone could not build the necessary market infrastructure. This era saw the birth of entities like the Reproductive Health Investors Alliance, which later evolved into Rhia Ventures.
• The Post-Roe Era: Following the erosion of federal protections for reproductive care, the urgency to build independent, resilient supply chains and care delivery models intensified. Organizations like Afaxys—a public benefit corporation that acts as the largest supplier of contraceptives to U.S. clinics—became the gold standard for how mission-aligned capital can secure essential health services.
• 2024–2025: The rise of specialized impact funds, such as RH Capital and the Orchid Capital Collective, has marked a transition toward "catalytic capital"—non-extractive, mission-first investment that prioritizes health equity as a key performance indicator (KPI) alongside financial returns.

Supporting Data: The Cost of Inaction vs. The Value of Innovation

The economic argument for investing in women’s health is overwhelming. A recent analysis by McKinsey suggests that closing the women’s health gap could add $1 trillion annually to the global economy. Conversely, the cost of racial and ethnic health disparities in the U.S. is estimated at $451 billion per year.

The disconnect between these figures and current investment behaviors is stark. Data from Rhia Ventures’ recent internal research highlights that 85% of reproductive and maternal health organizations still rely on grants as their primary funding source. Only 20% are actively pursuing investment capital, often because their operational models—such as community birth centers, birthworker collectives, and sexual health clinics—do not fit the traditional VC preference for high-growth, "exit-oriented" software models.

Moreover, 70% of these organizations report that their greatest unmet needs are infrastructure and operational expenses—the exact categories that traditional grantmakers often deem ineligible.

Strategic Innovations: The HEART Framework and Beyond

To bridge the gap between "innovation" and "impact," we must move away from the assumption that all health technology is inherently beneficial. A primary example of this failure is the recent history of telehealth, which, when deployed without community engagement, failed to mitigate prenatal care disparities among Indigenous women in North Dakota during the COVID-19 pandemic.

True innovation requires a rigorous health equity lens. At Rhia Ventures, we utilize the HEART Framework (Health Equity Assessment & Rating Tool) to evaluate potential investments. This framework ensures that companies are not just "disrupting" a market, but actively reducing disparities.

Case Studies in Success:

• Mae: By offering culturally competent, community-based doula care, Mae has reported a 26% reduction in C-section rates, demonstrating that clinical outcomes improve when care is grounded in cultural empathy.
• AOA: Developing new diagnostics for early-stage ovarian cancer, AOA directly targets the racial disparities in mortality rates associated with late-stage diagnoses.
• Cadence OTC: By streamlining the path to emergency contraception, Cadence OTC has reduced the logistical barriers that disproportionately impact low-income and rural patients.

Implications: Building a New Ecosystem

The future of reproductive and maternal health depends on our ability to replicate and scale alternative financing models. We must recognize that "Women’s Health" is not a monolith. Investors who flock to the sector for the sake of financial performance without requiring health equity analysis are merely resourcing the same pipelines that historically ignored the needs of women of color and low-income populations.

The Role of Systems-Level Change

Building a resilient system requires a concert of actors. We need:

1. Philanthropy to de-risk: Using grant money to fund the early, high-risk infrastructure that commercial capital ignores.
2. Impact Investors to scale: Providing the growth capital for organizations that have proven their model through community impact.
3. Policymakers to protect: Ensuring that reproductive health is viewed as an essential utility rather than a luxury good.

The rise of organizations like Fos Feminista, a global alliance of feminist groups, demonstrates that systems-level change is possible when resources are directed to those closest to the problems. These groups are not just service providers; they are architects of a new, more equitable care infrastructure.

Conclusion: How Funders Can Act Now

The transition to a more equitable reproductive health system is not a distant goal; it is a series of immediate, tactical choices. For capital holders looking to enter this space, the path forward is clear:

• Move beyond "Exit" metrics: Prioritize long-term operational sustainability over the desire for a quick liquidity event.
• Fund the "Invisible" Infrastructure: Acknowledge that the most critical needs—staffing, supply chain logistics, and community outreach—are often the most underfunded.
• Mandate Equity Audits: Require that all investments be screened not just for market size, but for their impact on marginalized populations.
• Engage with Ecosystem Builders: Partner with organizations like Rhia Ventures or the Orchid Capital Collective to learn how to deploy non-extractive, integrated capital.

The maternal health crisis is a test of our values as a society. If we continue to treat reproductive health as an afterthought in our investment portfolios, we are choosing to accept the status quo of inequality. If, however, we leverage the power of catalytic capital, we can transform the landscape of care, save millions of lives, and finally build a system that centers the health of all women.